Hawkins, Inc. reported record fourth-quarter sales and diluted earnings per share, driven by increased demand for health and immunity products. The company's Industrial and Water Treatment segments also contributed to the overall growth. The company is cautious about fiscal 2022 due to the uncertainty of consumer demand for health and immunity products.
Record sales in the fourth quarter of $163.0 million, a 23% year-over-year increase.
Record fourth quarter diluted earnings per share (EPS) of $0.43 was 91% higher than the same period of the prior year.
Health and Nutrition segment sales increased 63% due to increased consumer demand for health and immunity products.
Industrial segment sales increased 11% driven largely by a product mix shift to more sales of higher-priced manufactured, blended and repackaged products.
Hawkins anticipates continued execution on its long-term growth strategy in fiscal 2022. The company expects the Industrial segment to remain steady and the Water Treatment segment to rebound. However, they are cautious about the Health and Nutrition segment due to potential contraction if consumer behaviors migrate towards pre-pandemic levels.
Visualization of income flow from segment revenue to net income